• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON AND JOHNSON VISION CARE, INC. - US UNK-SOFT CONTACT LENSES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON AND JOHNSON VISION CARE, INC. - US UNK-SOFT CONTACT LENSES Back to Search Results
Catalog Number UNK-SOFT CONTACT LENSES
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
On 27dec2017 a johnson and johnson sales representative in (b)(6) reported a patient (pt) while wearing an unknown acuvue brand contact lens was diagnosed with ¿corneal endothelial cells decreased close to 1000 (affected eye not provided)¿.The eye care provider (ecp) advised the pt that a ¿corneal transplantation is to be necessary when the pt has cataract surgery sometime in the future¿.The ecp reported that the pt purchased contact lenses on the internet without a prescription and had an eye exam for the first time in many years.On 10jan2018 a call was placed to the sales representative and additional information was provided: the sales representative reported the information was received from the ecp on 27dec2017.On jan.10, 2018, the cr supervisor contacted our rep.The rep reported as follows: the suspect brand was not provided.The pt contact information was not provided.The pt was advised by the ecp regarding the importance of routine eye exams.On 15jan2018 the sales representative provided additional information: the pt presented to the clinic and did not bring the suspect lens.It is unknown what contact lens brand the pt was wearing at the time of the event.Additional information was requested.No additional information has been received.The event date is unknown.The lot number is unknown.It is also unknown if the suspect product is available.The event is being reported as a worst-case event as the diagnosis and treatment were not confirmed with the pts treating ecp.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
 
Manufacturer Narrative
On 24jan2018, our affiliate in (b)(6) received additional information from the johnson and johnson sales representative.The sales representative obtained the following information from the representative of the ecp: pt did not return for a f/u visit.The product is unknown as the pt did not bring the lens in question.The pt was previously prescribed 1-day acuvue define at the clinic.The ecp representative reported the pt ¿might wear a competitive color cl and called it ¿define¿.¿ no eye disorder was confirmed.No additional information has been received.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK-SOFT CONTACT LENSES
Type of Device
UNK-SOFT CONTACT LENSES
Manufacturer (Section D)
JOHNSON AND JOHNSON VISION CARE, INC. - US
7500 centurion parkway
jacksonville FL
MDR Report Key7206649
MDR Text Key97795944
Report Number1057985-2018-00008
Device Sequence Number1
Product Code LPL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 12/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue NumberUNK-SOFT CONTACT LENSES
Device Lot NumberUNK-UNK-SOFT CONTACT LENSES
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/27/2017
Initial Date FDA Received01/19/2018
Supplement Dates Manufacturer Received12/27/2017
Supplement Dates FDA Received02/20/2018
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-